OBJECTIVE: To compare medication use in patients suffering from cardiovascular disease with and without dementia. SUBJECTS: All inhabitants aged 75 and older in Lieto, Finland (n = 462, participation rate 82%). MEASUREMENTS: Direct standardised assessments of dementia and cardiovascular diseases. Quantification of drug use by self-report and by prescription and drug container checks. RESULTS: In multivariate analyses, the odds ratio for demented cardiovascular patients receiving any cardiovascular medication (use vs. non-use) was 0.31 (95% confidence interval 0.12-0.82). Compared to the non-demented, demented stroke patients were treated less often with antithrombotic agents (p = 0.041) and demented hypertensive patients less often with beta-blockers (p = 0.045). CONCLUSION: Demented cardiovascular patients, even mildly to moderately demented, were prescribed fewer evidence-based cardiovascular medications than non-demented patients. Copyright (c) 2006 S. Karger AG, Basel.
OBJECTIVE: To compare medication use in patients suffering from cardiovascular disease with and without dementia. SUBJECTS: All inhabitants aged 75 and older in Lieto, Finland (n = 462, participation rate 82%). MEASUREMENTS: Direct standardised assessments of dementia and cardiovascular diseases. Quantification of drug use by self-report and by prescription and drug container checks. RESULTS: In multivariate analyses, the odds ratio for demented cardiovascularpatients receiving any cardiovascular medication (use vs. non-use) was 0.31 (95% confidence interval 0.12-0.82). Compared to the non-demented, demented strokepatients were treated less often with antithrombotic agents (p = 0.041) and demented hypertensivepatients less often with beta-blockers (p = 0.045). CONCLUSION:Demented cardiovascularpatients, even mildly to moderately demented, were prescribed fewer evidence-based cardiovascular medications than non-demented patients. Copyright (c) 2006 S. Karger AG, Basel.
Authors: Gail B Rattinger; Sarah K Dutcher; Pankdeep T Chhabra; Christine S Franey; Linda Simoni-Wastila; Stephen S Gottlieb; Bruce Stuart; Ilene H Zuckerman Journal: Am J Geriatr Pharmacother Date: 2012-01-20
Authors: Stephanie Jb Vos; Chengjie Xiong; Pieter Jelle Visser; Mateusz S Jasielec; Jason Hassenstab; Elizabeth A Grant; Nigel J Cairns; John C Morris; David M Holtzman; Anne M Fagan Journal: Lancet Neurol Date: 2013-09-04 Impact factor: 44.182
Authors: Mark B Snowden; Lesley E Steinman; Lucinda L Bryant; Monique M Cherrier; Kurt J Greenlund; Katherine H Leith; Cari Levy; Rebecca G Logsdon; Catherine Copeland; Mia Vogel; Lynda A Anderson; David C Atkins; Janice F Bell; Annette L Fitzpatrick Journal: Int J Geriatr Psychiatry Date: 2017-02-01 Impact factor: 3.485
Authors: Yasser Alatawi; Richard A Hansen; Chiahung Chou; Jingjing Qian; Vishnu Suppiramaniam; Guanqun Cao Journal: Breast Cancer Date: 2020-09-09 Impact factor: 4.239